743
Participants
Start Date
May 31, 2004
Study Completion Date
July 31, 2006
Armodafinil 100 to 250 mg/day
Armodafinil 100-250 mg: once daily in the morning for patients with obstructive sleep apnea/hypopnea syndrome (OSAHS) or narcolepsy, once daily only on nights worked for patients with shift worker sleep disorder (SWSD).
St. George Hospital, Kogarah
New York University, New York
Clinilabs / Sleep Disorders In, New York
Montefiore Medical Center, The Bronx
Consolidated Clinical Trials, Pittsburgh
Capital Region Sleep Disorders, Carlisle
Center for Sleep/Wake Disorder, Chevy Chase
Regional Pulmonary and Sleep, Elkton
Sentara Norfolk General Hospit, Norfolk
Vital re:Search, Greensboro
Wake Research Associates, Raleigh
Duke University Hospital, Durham
Central Carolina Neurology Sle, Salisbury
Neurology Associates of Hickor, Hickory
SleepMed of South Carolina, Columbia
Lowcountry Lung and Critical, Charleston
Radiant Research Marietta, Marietta
Neurotrials Research, Atlanta
Sleep Disorders Center of GA, Atlanta
SLEEPMED, Inc., Macon
Sleep-Wake Disorder Center, Winter Park
PAB Clinical Research, Brandon
St. Petersburg Sleep Disorder, St. Petersburg
Hopital Guy de Chauliac, Montpellier
Klinikum der Philipps, Marburg
Sleep Disorders Ctr of Alabama, Birmingham
St. Thomas Sleep Disorders Cen, Nashville
Sleep Disorders Center, Hattiesburg
Chest Medicine Associates DBA, Louisville
Graves Gilbert Clinic, Bowling Green
Ohio Sleep Medicine-Neurosci, Dublin
St. Vincent Mercy Medical Cent, Toledo
North Coast Clinical Trials, Beechwood
Southwest Cleveland Sleep Cent, Middleburg Heights
Cleveland Clinic Foundation, Cleveland
Community Research, Crestview
Community Research Management, Cincinnati
Tri State Sleep Disorders Cent, Cincinnati
Dept Veterans Affairs Dayton, Dayton
Center for Sleep Disorders, Danville
University of Iowa Hospitals, Iowa City
Allegiance Research Specialist, Wauwatosa
St. Alexius Medical Center, Bismarck
Henry Lahmeyer, MD, Northfield
Peoria Pulmonary Associates, Peoria
Washington University School o, St Louis
Vince and Associates Clinical, Overland Park
Topeka Pulmonary, Topeka
Universitaires de Strasbourg, Strasbourg
Neurotrials Research of New Or, Metairie
Northshore Research Associates, Slidell
Central Arkansas Research, Hot Springs
Clinical Pharmaceutical Trials, Tulsa
Houston Sleep Center, Houston
VA Medical CenterSleep Diagnos, Houston
Sadler Clinic, The Woodlands
FutureSearch Trials, Austin
Radiant Research Salt Lake, Salt Lake City
Pulmonary Associates, PA, Phoenix
Psypharma Clinical Research, Phoenix
Clinical Rsch Center of Nevada, Las Vegas
Pacific Sleep Medicine Service, Los Angeles
Southwestern Research, Beverly Hills
St. Johns Medical Plaza Sleep, Santa Monica
Radiant Research San Diego, San Diego
Pacific Sleep Medicine Service, San Diego
BMR HealthQuest, San Diego
Hopital Antoine Beclere, Clamart
Pacific Sleep Medicine Service, Palm Springs
Advanced Clinical Research Ins, Anaheim
Hospital Henri-Mondor, Créteil
Sleep Clinic of San Francisco, San Francisco
Stanford University, Stanford
Swedish Sleep Medicine Institute, Seattle
McLean Hospital, Belmont
Neurocare, Inc., Newton
CNS Research Institute, Clementon
All Trials Clinical Research, Winston-Salem
Sleep Medicine Institute, Dallas
Royal Prince Alfred Hospital, Camperdown
Westmead Hospital, Wentworthville
Monash Medical Center, Clayton
Melbourne Sleep Disorders Ctr., East Melbourne
Canadian Sleep Institute, Calgary
Niagara Clinical Research, Niagara Falls
Sleep and Neuropsychiatry Cent, Scarborough Village
Baycrest Hospital, Toronto
City Clinical Hospital 33, Moscow
City Clinical Hospital 83, Moscow
Clinical Hospital Russian Scie, Saint Petersburg
Multifunction Center of Neurol, Samara
Omega Medical Research, Warwick
Sleep Clinic, Kitchener
Ottawa Hospital, Ottawa
West Parry Sound Health Center, Parry Sound
Toronto Western Hospital, Toronto
University of Freiburg, Freiburg im Breisgau
University of Regensburg, Regensburg
Hephata Klinik, Schwalmstadt
SomniCare Sleep Institute, San Juan
Lead Sponsor
Cephalon
INDUSTRY